All In Biotech

Drug Trial Radar · NCT06326047

A Research Study Comparing How Well Different Doses of the Medicine NN0519-0130 Lower Blood Sugar in People With Type 2 Diabetes

Investigation of the Safety and Efficacy of Once Weekly NNC0519-0130 in Participants With Type 2 Diabetes - a Dose Finding Study

Last checked: Nov 19, 2026Latest source record: Sep 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 299 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

299

Actual

Start

Mar 18, 2024

Primary completion

Sep 19, 2025

Study completion Oct 13, 2025

Sponsor

Lead sponsor
Novo Nordisk A/SNovo Nordisk (NVO)
Sponsor type
Industry
First posted
Mar 22, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will look at how well a new medicine called NNC0519-0130 helps people with type 2 diabetes lower their blood sugar and body weight. The study will test up to 7 different doses of NNC0519-0130. Which treatment participant will get is decided by chance. Participants will take 1-3 injections once a week. The study medicine will be injected under skin with a thin needle in the stomach, thigh, or upper arm. The study will last for about 40 weeks.

Conditions

  • Diabetes Mellitus, Type 2

Interventions

  • NNC0519-0130Drug

    NNC0519-0130 will be administered subcutaneously.

  • PlaceboDrug

    Placebo will be administered subcutaneously.

  • TrizepatideDrug

    Trizepatide will be administered subcutaneously.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in Glycated haemoglobin (HbA1c)Time frame: From baseline (week 0) to 12 weeks on a given maintenance dose

Locations

110 sites in 7 countries. Site status is shown where the registry gives one.

  • Velocity Clin Res-Chula Vista

    Chula Vista, California

  • Valley Research

    Fresno, California

  • 310 Clinical Research

    Inglewood, California

  • Velocity Clin Res San Diego

    La Mesa, California

  • First Valley Med Grp Lancaster

    Lancaster, California

  • Torrance Clin Res Inst, Inc.

    Lomita, California

  • Pacific Clinical Studies

    Los Alamitos, California

  • Velocity Clinical Research Westlake

    Los Angeles, California

  • Catalina Research Institute, LLC

    Montclair, California

  • Artemis Insitute for Clin Res

    San Diego, California

  • Med Partners, Inc.

    Toluca Lake, California

  • UCLA Health Southbay Endocrine

    Torrance, California

  • University Clin Investigators

    Tustin, California

  • Diablo Clinical Research, Inc.

    Walnut Creek, California

  • University of Colorado Hospital

    Aurora, Colorado

  • Innovative Research of W Florida Inc.

    Clearwater, Florida

  • Innovative Research of W FL

    Clearwater, Florida

  • International Research Associates, LLC_Miami

    Miami, Florida

  • Centricity Research

    Columbus, Georgia

  • Elite Clinical Trials

    Blackfoot, Idaho

  • Methodist Medical Center of Illinois

    Peoria, Illinois

  • University of Iowa

    Iowa City, Iowa

  • Centennial Medical Group

    Columbia, Maryland

  • MD Medical Research

    Oxon Hill, Maryland

  • Endo And Metab Cons

    Rockville, Maryland

  • Clinvest Research

    Springfield, Missouri

  • Mercury Str Med Grp, PLLC

    Butte, Montana

  • Velocity Clinical Research Lincoln

    Lincoln, Nebraska

  • Excel Clinical Network

    Las Vegas, Nevada

  • Palm Research Center Inc-Vegas

    Las Vegas, Nevada

  • Velocity Clinical Research Binghamton

    Binghamton, New York

  • PharmQuest Life Sciences LLC

    Greensboro, North Carolina

  • Accellacare Wilmington

    Wilmington, North Carolina

  • Diab & Endo Assoc of Stark Co

    Canton, Ohio

  • Velocity Clin Res_Cincinnati

    Cincinnati, Ohio

  • Velocity Clinical Research Springdale

    Cincinnati, Ohio

  • Providence Health Partners Ctr

    Dayton, Ohio

  • Advanced Med Res Maumee

    Maumee, Ohio

  • Velocity Clin Res Grants Pass

    Grants Pass, Oregon

  • Tristar Clin Investigations, PC

    Philadelphia, Pennsylvania

Showing 40 of 110 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.